The Center participated in live blogging from the 18th annual Conference on Retroviruses and Opportunistic Infections (CROI), held in Boston February 27 – March 2, 2011. Coverage includes updates on topical and systemic PrEP, HIV treatment adherence in resource-limited settings, and promising results from a rectal formulation of tenofovir gel.
This is the first in a week-long series exploring efforts to reduce HIV incidence via scaling up medical male circumcision (MC) in sub-Saharan Africa. Clinical trials have shown MC protects males by up to 60 percent from contracting HIV during vaginal sex. For more information, check out the Center’s recent report “Medical Male Circumcision as […]
Given the synergistic epidemics of HIV and TB in southern Africa, the question of how and when to integrate HIV and TB treatment in co-infected patients is a critical one. Here at the Conference on Retroviruses and Opportunistic Infections, Drs. Diane Havlir and Salim Abdool Karim presented important results from two randomized clinical trials attempting […]
Anthony Harries, MD, offered a powerful overview of the history of the global AIDS response from the vantage point of his work over more than a decade in the small African country of Malawi. He spoke at the plenary session of the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston Sunday. Malawi is a […]
Organizers of the International AIDS Society 2012 meeting to be held in Washington, DC, hosted a press conference Friday introducing key meeting partners to the media and highlighting the progress that needs to be made in the district’s own HIV epidemic. “This conference will be remembered as another pivotal moment in the epidemic,” said Elly […]
The following is a guest post by Yale University sophomore David Carel, a member of the Student Global AIDS Campaign. Originally from Philadelphia, David is an economics major with aspirations to work in health economics and policy. During a speech given by House Majority Leader Rep. Eric Cantor (R-VA) on Thursday evening, David participated in a […]
The World Health Organziation and UNITAID have announced a call for interest for individuals wishing to apply for membership of the Advisory Group on Funding Priorities (AGFP). UNITAID’s mission is to contribute to scaling up access to treatment for HIV/AIDS, malaria and tuberculosis for people in developing countries by leveraging price reductions of quality drugs and […]
The Senate will be crucial in the coming weeks as it considers the massive cuts in global health spending for fiscal year (FY) 2011, which the House is poised to pass late Friday. The Senate will also be the key to any effort to increase or even protect current funding for global health programs in […]
In the second of a two-part series with TB and HIV experts at the Bill & Melinda Gates Foundation, John Donnelly speaks with Dr. Peter Small, who runs the tuberculosis program at the Gates Foundation, regarding his thoughts on recent developments in the field of TB control and treatment, including the promise of the Gene Xpert rapid TB diagnostic tool. Dr. Small is a member of the Stop TB Partnership’s Coordinating Board, has done extensive research in the genetic variability of tuberculosis, and is a global expert in TB epidemiology, biology and control.
In the first of a two-part series with TB and HIV experts at the Bill & Melinda Gates Foundation, Dr. Stefano Bertozzi, director of HIV and tuberculosis programs at the Foundation, gives his thoughts on what lies ahead this year in HIV and TB building on key developments from the past year and a half. In his role, Dr. Bertozzi oversees grants in HIV vaccine development, biomedical prevention research, diagnostics development and resistance monitoring, and strategies for introduction and scaling-up of interventions. He has held past leadership roles at UNAIDS, the World Health Organization, the World Bank, and the National Institute of Public Health (INSP) in Mexico.